These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3501311

  • 1. Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins.
    Katz FE, Janossy G, Cumber A, Ross W, Blacklock HA, Tax W, Thorpe PE.
    Br J Haematol; 1987 Dec; 67(4):407-11. PubMed ID: 3501311
    [Abstract] [Full Text] [Related]

  • 2. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 3. Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.
    Preijers FW, De Witte T, Rijke-Schilder GP, Tax WJ, Wessels JM, Haanen C, Capel PJ.
    Scand J Immunol; 1988 Aug; 28(2):185-94. PubMed ID: 3261884
    [Abstract] [Full Text] [Related]

  • 4. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
    Xu M, Lu S, Shen B, Li Y.
    Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
    [Abstract] [Full Text] [Related]

  • 5. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
    Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.
    Blood; 1989 Aug 15; 74(3):1152-8. PubMed ID: 2473811
    [Abstract] [Full Text] [Related]

  • 6. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar 15; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 7. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA.
    J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
    Preijers FW, De Witte T, Wessels JM, Meyerink JP, Haanen C, Capel PJ.
    Br J Haematol; 1989 Feb 15; 71(2):195-201. PubMed ID: 2784323
    [Abstract] [Full Text] [Related]

  • 9. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
    Rasmussen RA, Counts SL, Lambert JM, Collinson AR.
    Cancer Immunol Immunother; 1992 Feb 15; 35(5):355-63. PubMed ID: 1394340
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.
    Izquierdo M, Balboa MA, Figuera A, López-Botet M.
    Clin Exp Immunol; 1988 Nov 15; 74(2):300-4. PubMed ID: 3265657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of an anti HLA-DR immunotoxin on leukaemia cells and hematopoietic progenitors.
    Demur C, Derocq JM, Poncelet P, Chiron M, Roubinet F, Jaffrezou JP, Bordier C, Laurent G.
    Leuk Res; 1989 Nov 15; 13(12):1047-54. PubMed ID: 2615463
    [Abstract] [Full Text] [Related]

  • 16. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG.
    Exp Hematol; 1992 May 15; 20(4):442-8. PubMed ID: 1373688
    [Abstract] [Full Text] [Related]

  • 17. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE, Taetle R, To D, Rhyner K.
    Blood; 1985 May 15; 65(5):1149-57. PubMed ID: 3888307
    [Abstract] [Full Text] [Related]

  • 18. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
    Fauser AA, Shustik C, Langleben A, Laurent G, Kanz L, Spurll GM, Price G, Ahlgren PD, Cooper BA.
    Clin Invest Med; 1988 Feb 15; 11(1):40-6. PubMed ID: 3284672
    [Abstract] [Full Text] [Related]

  • 19. Anti-CD2 (T, p50) intact ricin immunotoxins for GVHD-prophylaxis in allogeneic bone marrow transplantation.
    Uckun FM, Azemove SM, Myers DE, Vallera DA.
    Leuk Res; 1986 Feb 15; 10(2):145-53. PubMed ID: 3512922
    [Abstract] [Full Text] [Related]

  • 20. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
    Wu M, Tang SL, Zang RJ, Yu H.
    Int J Immunopharmacol; 1990 Feb 15; 12(2):235-9. PubMed ID: 2329015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.